Anixa is developing a vaccine to prevent the occurrence of #ovariancancer. Our #cancervaccine targets AMHR2-ED, a retired tissue-specific self protein that is expressed in the majority of ovarian cancers. More: https://bit.ly/3GqwfDf
Another Dr. Tuohy discovery: Anixa is developing a vaccine to prevent the occurrence of #ovariancancer.